The relationship between PD-L1 expression and its impact on the prognosis of endometrial cancer patients has been extensively explored, yielding inconsistent findings when correlated with tumour cells or immune cells and their associations with survival [83,84,87,93,97]. The gene discussed is CD274; the disease is endometrial cancer.